1. CTNI-14. A 3-ARM, PHASE IIA TRIAL OF SAFETY & EFFICACY OF OLINVACIMAB, A MONOCLONAL ANTIBODY TO VEGFR2 IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME WITH IMAGING AND PK/PD ASSESSMENTS: FINAL REPORT. (9th November 2020) Authors: Cher, Lawrence; Nowak, Anna; Iatropoulos, George; Bowyer, Samantha; Gan, Hui; Long, Anne Poh; Bynevelt, Michael; Jackson, Graeme; Lee, Seon Young; Lee, Weon Sup; Yoo, Jin-San Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗